Clinical Study Process
Home > Clinical Study Process
WELCOME TO Roshni CLINICAL
Your Clinical Study Journey
STEP 1
Apply to participate
STEP 1
Speak with an enrollment specialist
STEP 1
Informed Consent
STEP 1
Acceptance
STEP 1
Physical Screening
STEP 1
Visits
STEP 1
Follow-up
STEP 1
Apply to participate
THE MORE YOU KNOW!
Clinical Research Process
Clinical trials progress through phases, and each phase provides more information about the effectiveness and safety of the drug. The Food and Drug Administration (FDA) approves the trial at each phase before it proceeds. At Phase IV approval, the drug is then released to the general public.
Phase 1
his is the first time the study drug is experimented on humans for a specific indication or trial. It is tested on a smaller group, 20-100 healthy participants, with the condition/disease for multiple months to evaluate the safety and dosage of the drug.
Phase 1
his is the first time the study drug is experimented on humans for a specific indication or trial. It is tested on a smaller group, 20-100 healthy participants, with the condition/disease for multiple months to evaluate the safety and dosage of the drug.
Phase 1
his is the first time the study drug is experimented on humans for a specific indication or trial. It is tested on a smaller group, 20-100 healthy participants, with the condition/disease for multiple months to evaluate the safety and dosage of the drug.
Phase 1
his is the first time the study drug is experimented on humans for a specific indication or trial. It is tested on a smaller group, 20-100 healthy participants, with the condition/disease for multiple months to evaluate the safety and dosage of the drug.
FREQUENTLY ASKED QUESTIONS
Want to learn more about Roshni Clinical Studies? Have a question about our process? The answers to these and more can be found in our FAQ page!